### 📄 [Learning Protein Structure-Function Relationships through Knowledge‑guided Representation Decomposition](https://arxiv.org/abs/2605.23960)

* **Core Engineering Problem:**  
  State‑of‑the‑art protein language models produce highly entangled latent embeddings that obscure the biophysical cues needed for accurate function prediction, especially when training and test sets are split by structural similarity.

* **Methodology & Tech Stack:**  
  - **ProtDiS framework** – a knowledge‑guided decomposition that splits pretrained micro‑environment embeddings into *biologically grounded* (structure‑related) and *task‑relevant* subspaces.  
  - **Information‑Bottleneck regularization** to enforce a trade‑off between informativeness and compression, yielding independent, information‑efficient dimensions.  
  - Built on top of large pretrained protein models (e.g., ESM‑2, AlphaFold2 embeddings) using **PyTorch** for gradient‑based optimization; training performed on multi‑GPU servers (NVIDIA A100/RTX‑6000).  
  - Evaluation across **12 downstream tasks** (function annotation, subcellular localization, binding‑site prediction, etc.) with both sequence‑based and structure‑based data splits.

* **Biomedical Innovation:**  
  - Provides **interpretable, disentangled representations** that pinpoint structural motifs driving specific functions, facilitating mechanistic insight for drug target validation and enzyme engineering.  
  - Enhances **variant effect prediction** and functional annotation pipelines, accelerating precision‑medicine workflows that rely on accurate protein function inference from genomic data.  
  - By improving performance on structure‑based splits, ProtDiS better generalizes to novel folds, supporting the discovery of therapeutics against emerging pathogens and rare disease proteins.


### 📄 [Multimodal Alignment and Preference Optimization for Zero-Shot Conditional RNA Generation](https://arxiv.org/abs/2605.23961)

* **Core Engineering Problem:**  
  Enabling the generation of RNA sequences that reliably bind to a specified protein target while preserving the natural distribution of plausible RNA, a task that requires aligning heterogeneous modalities (RNA sequence, protein structure, and protein sequence) and optimizing functional fitness without collapsing the pretrained language model.

* **Methodology & Tech Stack:**  
  - **Large‑scale RNA pre‑training** on diverse corpora using transformer‑based language models (e.g., encoder‑decoder or decoder‑only architectures).  
  - **Multimodal Supervised Fine‑Tuning (SFT):** conditioning the RNA generator on protein features extracted from structural embeddings (e.g., AlphaFold‑derived 3‑D representations) and sequential embeddings (e.g., protein language models).  
  - **Direct Preference Optimization (DPO):** a reinforcement‑learning‑free preference‑based fine‑tuning step that leverages synthetic interaction scores to push the model toward higher binding affinity without explicit reward modeling.  
  - **Infrastructure:** GPU/TPU clusters for pre‑training and fine‑tuning; libraries such as PyTorch, Hugging Face Transformers, and biophysical toolkits (e.g., Rosetta, RNAstructure) for data preprocessing and evaluation.

* **Biomedical Innovation:**  
  The Moirain framework provides a scalable, zero‑shot pipeline for designing functional RNA therapeutics (e.g., aptamers, ribozymes, CRISPR guide RNAs) tailored to any protein of interest. By improving binding affinity and sequence diversity, it accelerates the discovery of RNA‑based diagnostics and treatments, reducing experimental cycles and enabling rapid response to emerging biomedical challenges.


### 📄 [Sensing Intelligence as a Trainable Metamaterial Property](https://arxiv.org/abs/2605.23967)

* **Core Engineering Problem:**  
  How can the mechanical body of a sensor be engineered to perform physical preprocessing of external stimuli, thereby simplifying the downstream neural‑network inference and dramatically reducing the number of required electronic transducers?

* **Methodology & Tech Stack:**  
  - **Differentiable physics simulation** (finite‑element or mass‑spring models) that is fully back‑propagation‑compatible.  
  - **Gradient‑based optimization** of metamaterial geometry parameters (unit‑cell shape, lattice topology, material distribution).  
  - **Neural network training** (typically lightweight CNN/MLP) that receives the internally generated signals as inputs; the sensing loss is propagated back to the physical design.  
  - **Hardware implementation** of the optimized metamaterial (e.g., 3‑D printed polymers, soft elastomers with embedded conductive traces).  
  - **Experimental validation** using a small set of off‑the‑shelf electronic sensors to demonstrate the reduced sensor count.

* **Biomedical Innovation:**  
  - **Wearable/implantable health monitors** can be made thinner, lighter, and lower‑power because the body itself filters and encodes physiological cues (e.g., pulse, respiration, tissue deformation) before they reach the electronics.  
  - **Edge‑centric health IoT** benefits from fewer ADC channels and reduced data bandwidth, enabling longer battery life and real‑time inference on TinyML‑class microcontrollers.  
  - **Personalized diagnostics**: the metamaterial geometry can be re‑trained for individual anatomy or specific biomarker signatures, offering a pathway to patient‑specific sensor skins without redesigning the entire electronic stack.


### 📄 [WTKO-CNN: Deep Learning Reveals Sequence Motifs Distinguishing Wild-Type and Knockout ATAC-seq Peaks](https://arxiv.org/abs/2605.24034)

* **Core Engineering Problem:**  
  Developing a robust computational pipeline that can accurately differentiate wild‑type (WT) from knockout (KO) ATAC‑seq peak sequences, while simultaneously extracting interpretable DNA motifs that drive the classification.

* **Methodology & Tech Stack:**  
  - **Algorithm:** Convolutional Neural Network (CNN) enhanced with an attention mechanism for sequence classification.  
  - **Interpretability:** Gradient‑based saliency maps to pinpoint influential nucleotides, followed by k‑mer extraction, clustering, and de‑novo motif discovery.  
  - **Validation Tools:** MEME Suite, TOMTOM, and HOMER for motif enrichment and comparison against known transcription‑factor binding sites.  
  - **Frameworks:** Likely implemented in TensorFlow or PyTorch; downstream motif analysis performed with standard bioinformatics command‑line tools.

* **Biomedical Innovation:**  
  By unveiling TF‑binding motifs that specifically distinguish WT from KO chromatin landscapes, the study provides mechanistic insights into how chromatin regulators reshape transcriptional programs. This knowledge accelerates the identification of regulatory drivers of disease, informs therapeutic target validation, and enhances the design of gene‑editing strategies for precision medicine.


### 📄 [AnnotateMissense: a genome-wide annotation and benchmarking framework for missense pathogenicity prediction](https://arxiv.org/abs/2605.24520)

* **Core Engineering Problem:**  
  Accurately classifying missense variants is difficult because pathogenicity depends on a heterogeneous mix of population frequencies, evolutionary conservation, transcript context, amino‑acid substitution severity, and outputs from existing predictors. A scalable system is needed to integrate these disparate data sources and deliver reliable genome‑wide predictions.

* **Methodology & Tech Stack:**  
  - Integrated hg38 missense variants from **dbNSFP v5.1** with **ANNOVAR** annotations, transcript/protein descriptors, **AlphaMissense** scores, and **ESM‑derived** protein‑language‑model features.  
  - Engineered additional amino‑acid/codon‑context features and incorporated population‑frequency metrics and established pathogenicity predictors.  
  - Trained and benchmarked a suite of **machine‑learning (XGBoost)** and deep‑learning models under controlled feature configurations, using a 303‑feature set and stratified 5‑fold cross‑validation.  
  - Performed circularity‑controlled ablations and temporal validation on newly released ClinVar variants.  
  - Deployed the final model to score **≈90 million** hg38 missense variants, publishing code and results on GitHub and Zenodo.

* **Biomedical Innovation:**  
  By delivering a high‑performance, genome‑wide missense pathogenicity score (MCC ≈ 0.94, ROC‑AUC ≈ 0.995), AnnotateMissense dramatically improves variant interpretation pipelines, enabling clinicians and researchers to prioritize disease‑causing mutations more reliably. This accelerates precision‑medicine diagnostics, supports genetic counseling, and provides a robust foundation for downstream functional studies and therapeutic target discovery.


### 📄 [C3P: Contrastive promoter‑protein pretraining yields representations capturing bacterial gene regulation](https://arxiv.org/abs/2605.25242)

* **Core Engineering Problem:**  
  Existing genome language models struggle to learn functional representations of regulatory DNA because they rely on noisy, reconstruction‑based pretraining, which fails to capture the subtle, rapidly evolving promoter signals that dictate gene expression.

* **Methodology & Tech Stack:**  
  - **Contrastive Learning Framework:** CLIP‑inspired architecture that aligns promoter sequences with their cognate protein embeddings.  
  - **Protein Supervision:** Leverages rich protein embeddings from state‑of‑the‑art protein language models (e.g., ESM, ProtBERT) as the supervisory signal.  
  - **Scale & Data:** Trains on ~88 M promoter‑protein pairs across bacterial genomes using transformer‑based encoders for both modalities.  
  - **Compute:** Distributed GPU training (e.g., NVIDIA A100) with mixed‑precision to keep cost far lower than conventional gLMs.

* **Biomedical Innovation:**  
  - Provides high‑quality, zero‑shot promoter embeddings that can predict regulatory annotations and retrieve co‑regulated genes without any experimental data, dramatically accelerating the mapping of bacterial regulatory networks.  
  - Enables rapid functional annotation of newly sequenced pathogens and microbiome members, supporting antimicrobial target discovery, synthetic biology circuit design, and precision microbiome therapeutics.


### 📄 [7 Tesla Quantitative MRI and Machine Learning for Exploratory Motor Subtype Stratification and Diagnosis in Parkinson's Disease](https://arxiv.org/abs/2605.24179)

* **Core Engineering Problem:**  
  Developing a reliable, low‑dimensional imaging‑based classifier that can distinguish healthy controls from Parkinson’s patients and further separate PD motor subtypes (PIGD vs. TD) despite a small cohort and high‑dimensional quantitative MRI data.

* **Methodology & Tech Stack:**  
  - **Imaging hardware:** 7 Tesla MRI scanner providing high‑resolution quantitative maps (e.g., R1, R2*, susceptibility, diffusion metrics).  
  - **Segmentation:** Deep‑learning U‑Net architecture trained on manually labeled brain regions; performance measured with Dice Similarity Coefficient (mean ≈ 0.86).  
  - **Feature engineering:** Extraction of region‑wise quantitative MRI values; subsequent feature‑selection pipeline to identify the most discriminative subset.  
  - **Classification:** Conventional ML classifiers (e.g., Support Vector Machine, Random Forest) evaluated via 5‑fold cross‑validation on three tasks (HC vs. PD, PIGD vs. TD, multiclass).  
  - **Evaluation metrics:** Accuracy, Area Under the ROC Curve (AUC) for both the “all‑features” (Approach A) and “selected‑features” (Approach B) strategies.

* **Biomedical Innovation:**  
  - Provides an objective, non‑invasive imaging signature that can support early PD diagnosis and precise motor‑subtype stratification, enabling personalized therapeutic decisions.  
  - Demonstrates that compact, interpretable feature sets derived from ultra‑high‑field qMRI can match or exceed performance of full‑feature models, facilitating translation to clinical workflows where computational resources and time are limited.  
  - Sets the stage for larger, multi‑site validation studies, potentially establishing a new standard for imaging‑guided PD phenotyping.


### 📄 [TIGER: Text-Informed Generalized Enzyme-Reaction Retrieval](https://arxiv.org/abs/2605.24489)

* **Core Engineering Problem:**  
  Achieving robust, bidirectional mapping between enzyme sequences and biochemical reactions while maintaining generalization across diverse datasets and distribution shifts.

* **Methodology & Tech Stack:**  
  - **Protein‑to‑text generation models** (e.g., transformer‑based language models fine‑tuned on protein sequences) to distill semantic textual embeddings.  
  - **Dynamic Gating Network** that adaptively fuses text‑derived embeddings with raw sequence features.  
  - **Structure‑Shared Feature Projector** aligning enzyme and reaction representations in a common latent space.  
  - Training under **bidirectional retrieval supervision** using contrastive loss functions and large‑scale enzyme‑reaction corpora.

* **Biomedical Innovation:**  
  By providing a unified, high‑fidelity representation of enzymes and their catalytic reactions, TIGER accelerates enzyme annotation, streamlines metabolic pathway engineering, and supports the rational design of biocatalysts—key steps toward scalable synthetic biology, personalized drug metabolism prediction, and next‑generation therapeutics.


### 📄 [MindAlign: Bridging EEG, Vision, and Language for Zero-Shot Visual Decoding](https://arxiv.org/abs/2605.24523)

* **Core Engineering Problem:**  
  Developing a robust, zero‑shot visual decoder that can translate non‑invasive EEG recordings into accurate image class predictions, despite the high dimensionality, low signal‑to‑noise ratio, and subject variability inherent in EEG data.

* **Methodology & Tech Stack:**  
  - **Two‑stage contrastive learning pipeline**:  
    1. **Self‑supervised pre‑training** of an EEG encoder via masked reconstruction on large unlabeled EEG corpora to capture spatio‑temporal regularities.  
    2. **Tri‑modal alignment** of EEG embeddings, CLIP‑style visual embeddings, and LLM‑generated textual descriptions using a contrastive loss that treats text as a semantic regularizer.  
  - **EEG Encoder architecture**:  
    - Graph‑attention layers over electrode channels for subject‑specific spatial weighting.  
    - Temporal‑spatial convolutional blocks (e.g., 1‑D depthwise separable convolutions) for efficient sequence modeling.  
    - Optional adapter modules for rapid per‑subject fine‑tuning.  
  - **Backbones**:  
    - Visual encoder: lightweight CLIP variant (CN‑CLIP) providing compact image embeddings.  
    - Language encoder: pretrained large language model (e.g., LLaMA‑7B) to generate concise textual descriptors for each class.  
  - **Training framework**: PyTorch + PyTorch‑Lightning, distributed data‑parallel on 8×A100 GPUs; mixed‑precision (AMP) for speed.  
  - **Evaluation**: Zero‑shot 200‑way classification on the Things‑EEG2 benchmark, statistical validation with paired Wilcoxon tests.

* **Biomedical Innovation:**  
  - **Non‑invasive visual prosthesis potential**: By decoding visual content directly from scalp EEG, the approach opens pathways for assistive communication devices for patients with severe motor impairments (e.g., locked‑in syndrome).  
  - **Semantic grounding**: Incorporating language embeddings aligns decoded neural activity with clinically meaningful concepts, facilitating interpretable brain‑computer interfaces (BCIs) for diagnosis and neurorehabilitation.  
  - **Scalable subject adaptation**: Graph‑attention and lightweight adapters enable rapid personalization without extensive per‑subject data collection, crucial for real‑world clinical deployment.  
  - **Open‑source reproducibility**: Full code release (GitHub) accelerates translation from research to prototype BCI hardware, supporting integration with portable EEG headsets and edge inference pipelines.


### 📄 [What Are We Actually Decoding? Source Attribution for Non-Invasive Brain-to-Language Retrieval](https://arxiv.org/abs/2605.24524)

* **Core Engineering Problem:**  
  Determining which components of a non‑invasive brain‑to‑language decoder actually reflect stimulus‑evoked neural information versus artefactual shortcuts (e.g., decoder priors, signal duration effects, or cross‑window contextual bias). The challenge is to *attribute* reported performance gains to their true source.

* **Methodology & Tech Stack:**  
  - **Data & Hardware:** Magnetoencephalography (MEG) recordings (and EEG for comparison) collected during stimulus‑locked audio presentation.  
  - **Signal Processing:** Variable‑length vs. fixed‑duration decoding windows; stimulus‑identity splits to control for structural leakage.  
  - **Machine‑Learning Models:** Retrieval pipelines that map MEG windows to audio embeddings, evaluated with Rank@1 (R@1) metrics.  
  - **Baseline Controls:** Signal‑blind Gaussian noise to quantify structural shortcuts.  
  - **Attribution Intervention:** **Group Context Bias (GCB)** – an inference‑time additive logit bias that aggregates sentence‑consistent evidence across windows while keeping the base score matrix and candidate pool unchanged.  
  - **Auditing Procedures:** Random‑group perturbations, attenuation of local MEG evidence, and cross‑modal (EEG) checks to verify that GCB’s effect stems from genuine contextual neural signals.

* **Biomedical Innovation:**  
  By rigorously separating true neural evidence from confounding artefacts, the work paves the way for reliable brain‑to‑language interfaces—crucial for assistive communication devices, silent speech prosthetics, and neuro‑rehabilitation tools. Accurate source attribution ensures that any clinical deployment rests on genuine cortical processing rather than exploitable dataset quirks, thereby increasing safety, interpretability, and regulatory trustworthiness of non‑invasive BCI systems.


### 📄 [Explainable Retinal Imaging for Prediction of Multi-Organ Dysfunction in Type 2 Diabetes](https://arxiv.org/abs/2605.24912)

* **Core Engineering Problem:**  
  Developing an accurate, clinically interpretable predictive model that integrates heterogeneous biomarkers (and retinal imaging features) to detect multi‑organ dysfunction in T2DM patients, while ensuring the model’s decisions can be trusted by clinicians.

* **Methodology & Tech Stack:**  
  - **Data engineering:** Construction of system‑level abnormality indices from routine laboratory tests (glucose, renal, lipid, inflammatory panels).  
  - **Modeling:** Supervised learning with Logistic Regression, Random Forest, and Gradient Boosting (e.g., XGBoost/LightGBM).  
  - **Interpretability:** SHapley Additive exPlanations (SHAP) for global and local feature attribution; partial dependence plots for dose‑response validation.  
  - **Software:** Python ecosystem – `pandas`, `scikit‑learn`, `xgboost`/`lightgbm`, `shap`, `matplotlib`/`seaborn`.  
  - **Reproducibility:** Open‑source code and data repository on GitHub.

* **Biomedical Innovation:**  
  By quantitatively linking easily obtainable biomarkers (and potentially retinal imaging signatures) to systemic organ dysfunction, the framework offers a non‑invasive, scalable tool for early risk stratification in diabetes. The explainable AI layer provides mechanistic insight (highlighting hyperglycaemia, renal impairment, dyslipidaemia, inflammation) that can guide personalized interventions and support precision‑medicine pipelines in routine clinical practice.


### 📄 [Explainable Multi-Task Retinal Imaging Reveals Microvascular Signals for Systemic Risk Stratification in Type 2 Diabetes: A Pilot Study](https://arxiv.org/abs/2605.24913)

* **Core Engineering Problem:**  
  Designing a deep‑learning system that can simultaneously predict multiple systemic health outcomes from retinal fundus images while providing reliable, anatomically grounded explanations of *what* retinal structures drive each prediction.

* **Methodology & Tech Stack:**  
  - **Multi‑task CNN architecture:** Shared backbone (likely a ResNet‑based encoder) with separate heads for glycaemic status, kidney abnormality, and multi‑system involvement.  
  - **Explainable AI tools:** Gradient‑weighted Class Activation Mapping (Grad‑CAM), anatomical masking (vessel vs. non‑vessel regions), and vessel‑alignment analysis to quantify the contribution of retinal vasculature.  
  - **Training framework:** PyTorch/TensorFlow on GPU clusters; data augmentation for fundus images; cross‑entropy loss with task‑specific weighting.  
  - **Evaluation metrics:** Area Under the ROC Curve (AUC) per task (best AUC ≈ 0.63 for kidney abnormality).  

* **Biomedical Innovation:**  
  Demonstrates that retinal microvascular morphology encodes measurable signals of systemic microvascular damage, especially early kidney dysfunction in type‑2 diabetes. By coupling multi‑task learning with rigorous XAI validation, the study provides an interpretable digital biomarker that could be integrated into routine ophthalmic screening, enabling non‑invasive, scalable risk stratification and fostering clinician trust in AI‑driven diagnostics.


### 📄 [Exact Variance and Fano Factor for Arbitrary Level Crossings in Stationary Gaussian Processes](https://arxiv.org/abs/2605.25278)

* **Core Engineering Problem:**  
  Traditional analyses of stochastic signals rely only on the mean crossing rate (Kac‑Rice formula), which ignores temporal correlations. The challenge is to obtain closed‑form expressions for the variance and Fano factor of level‑crossing events in smooth stationary Gaussian processes, thereby revealing whether such events cluster (super‑Poissonian) or regularize (sub‑Poissonian) over time.

* **Methodology & Tech Stack:**  
  - **Analytical derivation** of exact variance and Fano factor using extensions of the Kac‑Rice framework.  
  - Spectral‑density and autocorrelation analysis of smooth Gaussian processes (e.g., damped harmonic oscillator, Ornstein‑Uhlenbeck driven systems).  
  - Application of stochastic calculus, integral‑equation techniques, and asymptotic analysis to capture the full temporal correlation structure.  
  - Validation through numerical simulations of Gaussian processes with tunable damping and noise timescales.

* **Biomedical Innovation:**  
  - Provides a rigorous statistical tool to quantify the temporal organization of **neuronal spike trains** and other biomedical signals (EEG, EMG) that can be modeled as threshold crossings of Gaussian‑like fluctuations.  
  - Enables more accurate **parameter estimation** and **model selection** for neural encoding models, improving diagnostics for disorders characterized by abnormal firing patterns (e.g., epilepsy, Parkinson’s disease).  
  - Supports the design of **low‑power edge/TinyML spike‑detection algorithms** by supplying precise expectations for event variability, crucial for reliable real‑time health monitoring on IoT hardware.


### 📄 [ViroBench: Benchmarking Nucleotide Foundation Models on Viral Genomics Tasks](https://arxiv.org/abs/2605.25388)

* **Core Engineering Problem:**  
  The field lacks a unified, reproducible benchmark to assess how nucleotide foundation models (NFMs) understand viral biology and their latent bio‑security risks, especially when faced with phylogenetic and temporal distribution shifts.

* **Methodology & Tech Stack:**  
  - **Benchmark Design:** ViroBench comprises 18 scenarios across 4 task families (e.g., classification, generation, mutation impact prediction, and phylogenetic inference).  
  - **Model Suite:** 66 NFMs spanning transformer‑based architectures (e.g., BERT‑style, GPT‑style), convolutional encoders, and hybrid models.  
  - **Evaluation Pipeline:** Standardized metrics for biological fidelity (AUROC, F1, phylogenetic distance) and bio‑security risk (functional validity vs. statistical likelihood).  
  - **Ablation Studies:** Systematic manipulation of pre‑training taxonomic diversity, model size, and training objectives using PyTorch/HuggingFace libraries.  
  - **Infrastructure:** Distributed GPU clusters (NVIDIA A100) for large‑scale inference; reproducible Docker containers and CI pipelines for benchmark automation.

* **Biomedical Innovation:**  
  By exposing performance gaps under realistic evolutionary shifts and uncoupling statistical likelihood from functional virology, ViroBench guides the development of safer, more generalizable viral genome models. This accelerates downstream applications such as rapid pathogen detection, vaccine candidate ranking, and risk‑aware synthetic biology, while providing a concrete framework to enforce bio‑security constraints in clinical and public‑health deployments.


### 📄 [Querying structural and functional niches on spatial transcriptomics data](https://arxiv.org/abs/2410.10652)

* **Core Engineering Problem:**  
  Developing a robust computational framework that can query and retrieve spatially defined cellular “niches” across heterogeneous spatial transcriptomics (ST) datasets, while mitigating batch effects and preserving the intricate spatial relationships inherent to each niche.

* **Methodology & Tech Stack:**  
  - **Graph‑based niche representation:** each niche is modeled as a subgraph of cells/spots with edges encoding spatial proximity and/or molecular similarity.  
  - **Contrastive learning:** a self‑supervised objective trains a graph neural network (GNN) to produce discriminative niche embeddings that bring biologically similar niches together and push unrelated ones apart.  
  - **Adversarial batch‑effect correction:** a domain‑discriminator is coupled to the encoder, encouraging embeddings that are invariant to sequencing platform, sample preparation, or other technical covariates.  
  - **Implementation likely built on:** PyTorch / PyTorch‑Geometric for GNNs, Scanpy/AnnData for preprocessing, and standard contrastive learning libraries (e.g., SimCLR, MoCo).  

* **Biomedical Innovation:**  
  - Provides a quantitative, query‑driven way to compare micro‑environments such as tertiary lymphoid structures, tumor nodules, or immune niches across patients and cancer types.  
  - Enables discovery of niche signatures linked to prognosis, therapeutic response, or disease progression, facilitating precision medicine and the design of spatially targeted interventions.  
  - Bridges the gap between high‑dimensional spatial omics data and actionable clinical insights, accelerating the translation of spatial transcriptomics into routine pathology and oncology workflows.


### 📄 [Multi-Alignment Contrastive Learning for Enzyme–Reaction Retrieval](https://arxiv.org/abs/2512.08508)

* **Core Engineering Problem:**  
  Efficiently matching enzymes to their target biochemical reactions despite scarce pairwise supervision and the need to exploit higher‑order relationships within enzyme families and reaction sets.

* **Methodology & Tech Stack:**  
  - **Multi‑Alignment Contrastive Learning:** Jointly optimizes cross‑domain (enzyme ↔ reaction) compatibility and within‑domain (enzyme‑enzyme, reaction‑reaction) alignment.  
  - **Pairwise Catalytic Supervision** combined with **functional‑annotation‑driven relational alignment** (e.g., EC numbers, pathway membership).  
  - **Gromov–Wasserstein‑inspired regularization** to enforce geometric consistency between the learned enzyme and reaction embedding spaces.  
  - Likely deep encoders (e.g., transformer or CNN for protein sequences, graph neural networks for reaction graphs) feeding into a contrastive loss framework; training performed on large curated datasets (EnzymeMap, ReactZyme).  

* **Biomedical Innovation:**  
  - Accelerates **computational enzyme discovery** and **biocatalyst design**, enabling rapid identification of candidate enzymes for drug metabolism, synthetic biology, and therapeutic protein engineering.  
  - Improves early‑recognition metrics (BEDROC, enrichment factor), which translates to higher hit rates in virtual screening pipelines, reducing experimental workload and cost.  
  - By capturing functional organization of enzymes and reactions, the approach supports **precision metabolic engineering** and **personalized biocatalysis**, paving the way for novel treatments and bio‑manufacturing solutions.


### 📄 [Automated Place Preference Paradigm for Optogenetic Stimulation of the Pedunculopontine Nucleus Reveals Motor Arrest-Linked Preference Behavior](https://arxiv.org/abs/2601.12054)

* **Core Engineering Problem:**  
  Developing a low‑cost, fully autonomous closed‑loop system that can track a freely moving rat in real time, detect entry into a predefined zone, and trigger precise optogenetic stimulation with sub‑second latency—all on resource‑constrained edge hardware.

* **Methodology & Tech Stack:**  
  - **Hardware:** OpenMV Cam H7 Plus (ARM Cortex‑M7 MCU with integrated camera), custom optogenetic LED driver, and inexpensive micro‑controller I/O for stimulation control.  
  - **Software / Algorithms:** TinyML‑compatible convolutional neural network (CNN) models deployed on the OpenMV MCU for real‑time animal detection and position inference; deterministic finite‑state logic for zone entry detection and stimulation triggering; Python/C++ firmware for data logging and experiment orchestration.  
  - **System Integration:** Real‑time video stream → on‑device inference → closed‑loop digital output → optogenetic light pulse, all performed locally without cloud dependence.

* **Biomedical Innovation:**  
  Provides a scalable, unbiased platform for probing how motor suppression in the rostral pedunculopontine nucleus interacts with reinforcement circuitry, enabling high‑throughput behavioral phenotyping and accelerating pre‑clinical studies of movement‑disorder and motivation‑related disorders. The edge‑centric design reduces experimental variability, cost, and setup complexity, facilitating broader adoption in neuroscience labs and paving the way for translational neuro‑engineering applications.


### 📄 [Non-Invasive Reconstruction of Intracranial EEG Across the Deep Temporal Lobe from Scalp EEG based on Conditional Normalizing Flow](https://arxiv.org/abs/2603.03354)

* **Core Engineering Problem:**  
  Accurately generating high‑fidelity intracranial EEG (iEEG) waveforms from non‑invasive scalp EEG (sEEG) recordings while preserving the stochastic, high‑frequency characteristics of deep‑brain signals and avoiding the mode‑collapse pitfalls of conventional generative models.

* **Methodology & Tech Stack:**  
  - **Algorithm:** Conditional Normalizing Flow (CNF) with reversible transformations to model the full conditional distribution \(p(\text{iEEG} \mid \text{sEEG})\).  
  - **Architecture:** Multi‑scale CNF backbone augmented with self‑attention layers for fine‑grained temporal resolution and long‑range dependency capture.  
  - **Training Framework:** Likely implemented in **PyTorch** (or TensorFlow) utilizing GPU acceleration for efficient back‑propagation through invertible layers.  
  - **Data:** Publicly available synchronized sEEG–iEEG dataset; preprocessing includes band‑pass filtering, artifact removal, and alignment.

* **Biomedical Innovation:**  
  Provides a non‑invasive window into deep temporal‑lobe neural dynamics, enabling clinicians to assess functional connectivity, seizure foci, and other pathophysiological markers without surgical implantation. This could dramatically reduce patient risk, expand access to high‑resolution brain monitoring, and accelerate research on deep‑brain disorders such as epilepsy and memory‑related pathologies.


### 📄 [Multi-Modal Machine Learning for Population- and Subject-Specific lncRNA-Type 2 Diabetes Association Analysis](https://arxiv.org/abs/2605.20747)

* **Core Engineering Problem:**  
  Developing a robust computational pipeline that fuses heterogeneous molecular modalities—gene‑expression levels, predicted secondary‑structure attributes, and raw sequence descriptors—to reliably detect lncRNA signatures of Type‑2 Diabetes while coping with limited, high‑dimensional biomedical datasets.

* **Methodology & Tech Stack:**  
  - **Feature Extraction:** Quantitative expression metrics, secondary‑structure predictions (e.g., minimum free energy, base‑pairing probabilities), and k‑mer/physicochemical sequence features for each of the ten target lncRNAs.  
  - **Machine‑Learning Models:** Eight classifiers (e.g., Random Forest, Gradient Boosting, Support Vector Machine, Logistic Regression, XGBoost, LightGBM, Neural Networks, k‑Nearest Neighbors) evaluated under stratified k‑fold, leave‑one‑out cross‑validation (LOOCV), and repeated hold‑out schemes for unbiased performance estimation.  
  - **Interpretability:** SHapley Additive exPlanations (SHAP) applied at the subject level to rank feature contributions and pinpoint dominant lncRNAs (MEG3) across cohorts.  
  - **Software Stack:** Python ecosystem (pandas, NumPy, scikit‑learn, XGBoost/LightGBM, RNAstructure or ViennaRNA for secondary‑structure, SHAP library), executed on standard CPU/GPU workstations.

* **Biomedical Innovation:**  
  The framework translates multi‑modal genomic signals into actionable, patient‑specific disease association profiles, revealing how distinct molecular feature types (expression vs. structural vs. sequence) drive T2D risk. By aligning ML‑derived insights with conventional statistical findings, it bolsters mechanistic understanding of lncRNA involvement in diabetes and paves the way for precision‑medicine strategies that could guide early diagnosis, risk stratification, and lncRNA‑targeted therapeutics.


### 📄 [From Sleep Staging to Spindle Detection: A Case Study on End-to-End Automated Sleep Analysis](https://arxiv.org/abs/2505.05371)

* **Core Engineering Problem:**  
  Building a seamless, end‑to‑end pipeline that couples validated sleep‑stage classification with spindle detection, while preserving or surpassing human inter‑rater reliability and handling the propagation of errors between the two stages.

* **Methodology & Tech Stack:**  
  - **Sleep Staging:** RobustSleepNet – a deep‑learning architecture (CNN/temporal‑convolutional network) trained on polysomnography (PSG) data.  
  - **Spindle Detection:** SUMOv2 – a state‑of‑the‑art spindle detector leveraging spectral‑temporal features and supervised learning.  
  - **Integration & Evaluation:** Python ecosystem (PyTorch, NumPy, SciPy), automated batch processing of PSG recordings, statistical replication of a prior expert‑based bipolar‑disorder study.  
  - **Deployment Platform:** SomnoBot – a privacy‑preserving cloud/edge‑ready service (containerized, API‑driven) for scalable analysis of EEG signals.

* **Biomedical Innovation:**  
  - **Clinical Impact:** Provides rapid, reproducible quantification of macro‑ (sleep stages) and micro‑ (spindles) sleep architecture, enabling objective biomarkers for neuropsychiatric conditions such as bipolar disorder.  
  - **Scalability:** Automates analyses that previously required months of manual scoring, opening the door to large‑scale population studies and longitudinal monitoring.  
  - **Standardization:** By matching or exceeding inter‑rater agreement, the pipeline reduces observer bias, supporting more consistent diagnostic criteria and facilitating integration into tele‑sleep medicine and home‑based EEG devices.


### 📄 [Efficient Imputation for Patch-based Missing Single-cell Data via Cluster-regularized Optimal Transport](https://arxiv.org/abs/2601.14653)

* **Core Engineering Problem:**  
  Single‑cell sequencing datasets often contain large, contiguous “patches” of missing values, which break the assumptions of conventional imputation methods and lead to biased downstream analyses.

* **Methodology & Tech Stack:**  
  - **Algorithmic core:** Cluster‑regularized Optimal Transport (CROT), which couples optimal transport with cluster‑level constraints to preserve global data geometry while filling missing patches.  
  - **Key techniques:** Patch‑wise similarity modeling, entropy‑regularized OT solvers, and cluster‑based regularization to guide transport plans.  
  - **Software stack:** Implemented in Python, leveraging the POT (Python Optimal Transport) library, NumPy/SciPy for linear algebra, and optional GPU acceleration via CuPy/JAX for large‑scale datasets.  
  - **Data format:** Tabular single‑cell expression matrices (genes × cells) with missing entries encoded as NaNs.

* **Biomedical Innovation:**  
  By delivering high‑fidelity imputation even when substantial portions of the transcriptomic matrix are absent, CROT enables more reliable cell‑type identification, trajectory inference, and differential expression analysis. This directly improves the interpretability of single‑cell studies in disease profiling, drug response screening, and precision medicine pipelines, accelerating the translation of high‑dimensional genomics data into actionable clinical insights.


### 📄 [Accelerating De Novo Genome Assembly via Quantum-Assisted Graph Optimization with Bitstring Recovery](https://arxiv.org/abs/2602.00156)

* **Core Engineering Problem:**  
  De novo genome assembly requires finding Hamiltonian/Eulerian paths in massive assembly graphs, a task that scales combinatorially and becomes a bottleneck for timely, accurate reconstruction of whole genomes.

* **Methodology & Tech Stack:**  
  - **Hybrid quantum‑classical workflow**: classical pre‑processing to construct the assembly graph, followed by a quantum optimization stage.  
  - **Higher‑Order Binary Optimization (HOBO)** formulation of the path‑finding problem.  
  - **Variational Quantum Eigensolver (VQE)** on gate‑based quantum processors to approximate the ground state of the HOBO Hamiltonian.  
  - **Novel bit‑string recovery mechanism** to guide the optimizer through the discrete solution space and improve convergence.  
  - Comparative benchmarking against state‑of‑the‑art classical solvers (e.g., integer linear programming, simulated annealing).

* **Biomedical Innovation:**  
  By potentially reducing the time and computational resources needed for high‑quality genome assembly, the approach accelerates downstream applications such as rapid pathogen detection, population‑scale genomic studies, and the generation of personalized reference genomes—critical steps toward real‑time precision medicine and outbreak response.


### 📄 [JEPA-DNA: Grounding Genomic Foundation Models through Joint-Embedding Predictive Architectures](https://arxiv.org/abs/2602.17162)

* **Core Engineering Problem:**  
  Current Genomic Foundation Models (GFMs) are trained primarily with token‑level generative objectives (masked language modeling or next‑token prediction), which excel at capturing local sequence syntax but fail to embed high‑level functional semantics needed for downstream biological tasks.

* **Methodology & Tech Stack:**  
  - Introduces **JEPA‑DNA**, a model‑agnostic continual‑training framework that couples a **Joint‑Embedding Predictive Architecture (JEPA)** with standard generative losses.  
  - Learns **global sequence embeddings** and forces the model to predict the functional representation of masked genomic segments, effectively turning the training signal into a semantic alignment problem.  
  - Built on **transformer‑based GFMs** (e.g., BERT‑style or GPT‑style architectures) using **PyTorch**, with GPU acceleration (NVIDIA A100/RTX) for large‑scale pre‑training.  
  - Open‑source implementation provided at https://github.com/NVIDIA-Digital-Bio/JEPA-DNA.

* **Biomedical Innovation:**  
  By grounding DNA representations in functional latent space, JEPA‑DNA markedly improves linear‑probe and zero‑shot performance across a wide spectrum of genomics benchmarks. This enables more accurate prediction of regulatory elements, pathogenic variants, and gene‑expression effects, accelerating translational pipelines for diagnostics, precision medicine, and therapeutic target discovery.


### 📄 [Induction Meets Biology: Mechanisms of Repeat Detection in Protein Language Models](https://arxiv.org/abs/2602.23179)

* **Core Engineering Problem:**  
  Determining how large protein language models internally recognize both exact and approximate repeating motifs in amino‑acid sequences, and uncovering the specific attention mechanisms that enable this capability.

* **Methodology & Tech Stack:**  
  - Transformer‑based protein language models (e.g., ESM, ProtBERT) trained with masked‑token prediction.  
  - Dissection of attention heads to identify “general positional” versus “biologically specialized” heads (e.g., neurons encoding amino‑acid similarity).  
  - Analysis of induction heads that align tokens across repeat instances, revealing a two‑stage detection pipeline (feature construction → inductive alignment).  

* **Biomedical Innovation:**  
  - Provides mechanistic insight into how PLMs capture repeat‑driven structural and functional signals, critical for interpreting disease‑associated repeat expansions (e.g., Huntington’s, collagen disorders).  
  - Enables more reliable annotation of repeat regions in proteomes, facilitating downstream applications such as protein engineering, drug target identification, and the design of therapeutics that exploit repeat‑mediated interactions.